B-cell lymphoma 9-like protein (BCL9L) is a transcriptional regulator that acts as an activator. BCL9L promotes beta-catenin transcriptional activity and plays a role in tumorigenesis [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/ Q86UU0].
Alternative names for
BCL9L Antibody include Protein BCL9-2 antibody,
protein BCL9-2 antibody,
B-cell CLL/lymphoma 9-like protein antibody,
BCL9-like protein antibody,
B-cell lymphoma 9-like protein antibody,
nuclear co-factor of beta-catenin signalling antibody.